Precipio Announces First US Government Customer for ICE COLD-PCR Mutation Enrichment Technology Genetics Investing
Histogenics and FDA Conclude Discussions Regarding NeoCart Phase 3 Clinical Trial Data and Regulatory Pathway Genetics Investing
Axovant Sciences Announces Pricing of $30 Million Public Offering of Common Shares Genetics Investing
